SURMOUNT-OSA Study Highlights Potential Dual-Action Benefits of Novel Therapy for Obesity ORLANDO, Fla., June 21, 2024 /PRNewswire/ — Today, findings from the SURMOUNT-OSA, a study of tirzepatide in patients with obstructive sleep apnea (OSA) and obesity, were announced, revealing…